Onc Pharm Flashcards
MOA of methotrexate?
Folic acid analog that inhibits dihydrofolate reductase (DHF reductase), so decreased dTMP –> decreased DNA and protein synthesis.
Toxicity of MTX?
Myelosuppression, macrovesicular fatty change in liver, mucositis, teratogenic
What to administer with methotrexate to prevent myelosuppression?
Leucovorin
5-FU MOA?
Pyrimidine analog bioactivated to 5F-dUMP which covalently complexes folic acid. Inhibits thymidylate synthesis.
Toxicity of 5-FU?
Myelosuppression and photosensitivity.
Rescue for 5-FU?
Uridine
Cytarabine MOA?
Pyrimidine analog - inhibits DNA polymerase
Toxicity of cytarabine?
Leukopenia, thrombocytopenia, megaloblastic anemia.
CYTarabine causes panCYTopenia
Azathioprine
6-mercaptopurine (6-MP)
6-thioguanine
Purine (thiol) analogs - decrease de novo purine synthesis
Thiols toxicity?
Bone marrow, GI, liver
Dactinomycin MOA?
Intercalates in DNA
Dactinomycin toxicity?
Myelosuppression
Doxorubicin MOA?
Generates free radicals, which intercalate in DNA and break DNA, resulting in decreased DNA replication
Doxorubicin toxicity?
Cardiotoxicity (dilated cardiomyopathy), myelosuppression, alopecia.
What to give to prevent doxorubicin cardiotoxicity?
Dexrazoxane - iron chelating agent
Bleomycin MOA?
Induces free radical formation, which cause breaks in DNA strands.
Bleomycin toxicity?
Pulmonary fibrosis, skin changes, mucositis.
Cyclophosphamide, ifosfamide
Alkylating agents that covalently X-link DNA and require liver bioactivation.